202 related articles for article (PubMed ID: 7099785)
1. Atypical measles syndrome: pathologic and serologic findings.
Annunziato D; Kaplan MH; Hall WW; Ichinose H; Lin JH; Balsam D; Paladino VS
Pediatrics; 1982 Aug; 70(2):203-9. PubMed ID: 7099785
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response.
Iankov ID; Pandey M; Harvey M; Griesmann GE; Federspiel MJ; Russell SJ
J Virol; 2006 Sep; 80(17):8530-40. PubMed ID: 16912303
[TBL] [Abstract][Full Text] [Related]
3. Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination.
Dilraj A; Sukhoo R; Cutts FT; Bennett JV
Vaccine; 2007 May; 25(21):4170-4. PubMed ID: 17408818
[TBL] [Abstract][Full Text] [Related]
4. [An atypical measles case presenting with severe cervical spasm].
Oztoprak N; Celebi G; Temiz E
Mikrobiyol Bul; 2006 Oct; 40(4):401-5. PubMed ID: 17205700
[TBL] [Abstract][Full Text] [Related]
5. Rural Kenya: measles during pregnancy and early infancy.
Arya SC; Agarwal N
J Infect Dis; 2006 Jan; 193(1):165-6; author reply 166-7. PubMed ID: 16323147
[No Abstract] [Full Text] [Related]
6. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
[TBL] [Abstract][Full Text] [Related]
7. Experimental measles. I. Pathogenesis in the normal and the immunized host.
McChesney MB; Miller CJ; Rota PA; Zhu YD; Antipa L; Lerche NW; Ahmed R; Bellini WJ
Virology; 1997 Jun; 233(1):74-84. PubMed ID: 9201218
[TBL] [Abstract][Full Text] [Related]
8. Altered reactivity to measles virus in previously vaccinated children.
Gokiert JG; Beamish WE
Can Med Assoc J; 1970 Oct; 103(7):724-7. PubMed ID: 5506106
[TBL] [Abstract][Full Text] [Related]
9. [Unsuitability of children revaccination against measles].
Bolotovskiĭ VM; Titova NS
Sov Med; 1981; (9):43-8. PubMed ID: 7313794
[No Abstract] [Full Text] [Related]
10. Measles vaccine failures: lack of sustained measles-specific immunoglobulin G responses in revaccinated adolescents and young adults.
Cohn ML; Robinson ED; Faerber M; Thomas D; Geyer S; Peters S; Martin M; Martin A; Sobel D; Jones R
Pediatr Infect Dis J; 1994 Jan; 13(1):34-8. PubMed ID: 8170730
[TBL] [Abstract][Full Text] [Related]
11. Measles IgA in the nasal washings of adult volunteers and children immunized intranasally with measles vaccine L-16.
Liashenko VA; Krasnova VP; Youminova NV
Hum Antibodies; 1999; 9(3):143-8. PubMed ID: 10690626
[TBL] [Abstract][Full Text] [Related]
12. [The HLA antigen system and the immune response in measles vaccination].
Kharit SM; Kapralova MA
Tr Inst Im Pastera; 1985; 62():72-5. PubMed ID: 3843366
[No Abstract] [Full Text] [Related]
13. Evaluation of recombinant vaccinia virus--measles vaccines in infant rhesus macaques with preexisting measles antibody.
Zhu Yd; Rota P; Wyatt L; Tamin A; Rozenblatt S; Lerche N; Moss B; Bellini W; McChesney M
Virology; 2000 Oct; 276(1):202-13. PubMed ID: 11022008
[TBL] [Abstract][Full Text] [Related]
14. Typical, modified, and atypical measles.
Welliver RC; Cherry JD; Holtzman AE
Arch Intern Med; 1977 Jan; 137(1):39-41. PubMed ID: 831653
[TBL] [Abstract][Full Text] [Related]
15. Distinguishing between primary measles infection and vaccine failure reinfection by IgG avidity assay.
Hamkar R; Mahmoodi M; Nategh R; Jelyani KN; Eslami MB; Mohktari-Azad T
East Mediterr Health J; 2006 Nov; 12(6):775-82. PubMed ID: 17333822
[TBL] [Abstract][Full Text] [Related]
16. [Study on the subclinical infection of the recipients of measles vaccine].
Wu T; Wang SL; Xiang YZ
Zhonghua Liu Xing Bing Xue Za Zhi; 1996 Apr; 17(2):70-2. PubMed ID: 8758397
[TBL] [Abstract][Full Text] [Related]
17. Optimal age for vaccinating Nigerian children against measles. I. Neonatal antibody profile and subsequent susceptibility to measles.
Harry TO; Ogunmekan DA
Trop Geogr Med; 1981 Dec; 33(4):375-8. PubMed ID: 7342384
[TBL] [Abstract][Full Text] [Related]
18. Antimeasles immunoglobulin g for serologic diagnosis of otosclerotic hearing loss.
Karosi T; Kónya J; Petkó M; Szabó LZ; Pytel J; Jóri J; Sziklai I
Laryngoscope; 2006 Mar; 116(3):488-93. PubMed ID: 16540914
[TBL] [Abstract][Full Text] [Related]
19. National serologic survey of measles immunity among persons 6 years of age or older, 1988-1994.
Hutchins SS; Redd SC; Schrag S; Kruszon-Moran D; Wooten K; McQuillan GM; Bellini W; Meyer PA; Hadler S
MedGenMed; 2001 Jan; ():E5. PubMed ID: 11320344
[TBL] [Abstract][Full Text] [Related]
20. Unusual presentation of measles giant cell pneumonia in a patient with acquired immunodeficiency syndrome.
Okamura A; Itakura O; Yoshioka M; Kubota M; Kikuta H; Kobayashi K
Clin Infect Dis; 2001 Feb; 32(3):E57-8. PubMed ID: 11170972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
